Ani pharmaceuticals announces results from new day clinical trial of iluvien® for use in patients with diabetic macular edema (dme)

Trial evaluated number of supplemental injections needed for the treatment of dme for patients on iluvien versus the aflibercept arm

ANIP Ratings Summary

ANIP Quant Ranking